Gillen DL - Search Results

1

Elevated risk of stroke among patients with end-stage renal disease.

Seliger SL, Gillen DL, Longstreth WT Jr, Kestenbaum B, Stehman-Breen CO. Seliger SL, et al. Among authors: gillen dl. Kidney Int. 2003 Aug;64(2):603-9. doi: 10.1046/j.1523-1755.2003.00101.x. Kidney Int. 2003. PMID: 12846756

2

Decreased renal function among adults with a history of nephrolithiasis: a study of NHANES III.

Gillen DL, Worcester EM, Coe FL. Gillen DL, et al. Kidney Int. 2005 Feb;67(2):685-90. doi: 10.1111/j.1523-1755.2005.67128.x. Kidney Int. 2005. PMID: 15673317

3

Vascular access survival and incidence of revisions: a comparison of prosthetic grafts, simple autogenous fistulas, and venous transposition fistulas from the United States Renal Data System Dialysis Morbidity and Mortality Study.

Gibson KD, Gillen DL, Caps MT, Kohler TR, Sherrard DJ, Stehman-Breen CO. Gibson KD, et al. Among authors: gillen dl. J Vasc Surg. 2001 Oct;34(4):694-700. doi: 10.1067/mva.2001.117890. J Vasc Surg. 2001. PMID: 11668326

4

Assessment of a policy to reduce placement of prosthetic hemodialysis access.

Gibson KD, Caps MT, Kohler TR, Hatsukami TS, Gillen DL, Aldassy M, Sherrard DJ, Stehman-Breen CO. Gibson KD, et al. Among authors: gillen dl. Kidney Int. 2001 Jun;59(6):2335-45. doi: 10.1046/j.1523-1755.2001.00751.x. Kidney Int. 2001. PMID: 11380838

5

Risk factors for hip fracture among patients with end-stage renal disease.

Stehman-Breen CO, Sherrard DJ, Alem AM, Gillen DL, Heckbert SR, Wong CS, Ball A, Weiss NS. Stehman-Breen CO, et al. Among authors: gillen dl. Kidney Int. 2000 Nov;58(5):2200-5. doi: 10.1111/j.1523-1755.2000.00394.x. Kidney Int. 2000. PMID: 11044242

6

Increased risk of hip fracture among patients with end-stage renal disease.

Alem AM, Sherrard DJ, Gillen DL, Weiss NS, Beresford SA, Heckbert SR, Wong C, Stehman-Breen C. Alem AM, et al. Among authors: gillen dl. Kidney Int. 2000 Jul;58(1):396-9. doi: 10.1046/j.1523-1755.2000.00178.x. Kidney Int. 2000. PMID: 10886587

7

Anthropometric measures and risk of death in children with end-stage renal disease.

Wong CS, Gipson DS, Gillen DL, Emerson S, Koepsell T, Sherrard DJ, Watkins SL, Stehman-Breen C. Wong CS, et al. Among authors: gillen dl. Am J Kidney Dis. 2000 Oct;36(4):811-9. doi: 10.1053/ajkd.2000.17674. Am J Kidney Dis. 2000. PMID: 11007685

8

Risk factors and mortality associated with calciphylaxis in end-stage renal disease.

Mazhar AR, Johnson RJ, Gillen D, Stivelman JC, Ryan MJ, Davis CL, Stehman-Breen CO. Mazhar AR, et al. Kidney Int. 2001 Jul;60(1):324-32. doi: 10.1046/j.1523-1755.2001.00803.x. Kidney Int. 2001. PMID: 11422768

9

Prescription of hormone replacement therapy in postmenopausal women with renal failure.

Stehman-Breen CO, Gillen D, Gipson D. Stehman-Breen CO, et al. Kidney Int. 1999 Dec;56(6):2243-7. doi: 10.1046/j.1523-1755.1999.00793.x. Kidney Int. 1999. PMID: 10594801

10

Determinants of type and timing of initial permanent hemodialysis vascular access.

Stehman-Breen CO, Sherrard DJ, Gillen D, Caps M. Stehman-Breen CO, et al. Kidney Int. 2000 Feb;57(2):639-45. doi: 10.1046/j.1523-1755.2000.00885.x. Kidney Int. 2000. PMID: 10652042

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results